RCi004-A + HTT GC #H34-32_T34-23
RCi004-A-1
General
Cell Line |
|
| hPSCreg name | RCi004-A-1 |
| Cite as: | RCi004-A-1 |
| Alternative name(s) |
RCi004-A + HTT GC #H34-32_T34-23
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
|
| Last update | 20th December 2022 |
| User feedback | |
Provider |
|
| Generator | Bioneer (BION) |
| Distributors | |
External Databases |
|
| BioSamples | SAMEA7462886 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed.
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA3106020 |
Ethics
Also have a look at the ethics information for the parental line
RCi004-A
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
RCi004-A.
|
|
| Passage number reprogrammed | 48 |
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Episomal |
| Genes | |
| Is reprogramming vector detectable? |
No |
| Methods used |
PCR
|
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
No |
| Derived under GMP? |
No |
| Available as clinical grade? |
No |
Culture Conditions
| Surface coating | Matrigel/Geltrex |
| Feeder cells |
No |
| O2 Concentration | 20 % |
| CO2 Concentration | 5 % |
| Medium |
mTeSR™ 1
|
Characterisation
No characterisation data could be found for this subclone. Please open parental cell line RCi004-A .Genotyping
Karyotyping (Cell Line) |
|
Other Genotyping (Cell Line) |
Genetic Modification
| Disease/phenotype related modifications |
|

Login to share your feedback, experiences or results with the research community.